0 results available. Select is focused ,type to refine list, press Down to open the menu,
Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. It invests in public equity markets of the Un...
The following section summarizes insights on Invesco Biotechnology & Genome ETF's Debt / Common Equity:
We've identified the following companies as similar to Invesco Biotechnology & Genome ETF because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Debt / Common Equity in the risk category include:
A ratio that measures the level of the debt relative to the book value of common equity.
Debt / Equity is defined as:
Total Debt
(/) Total Common Equity
(=) Debt / Equity
Debt / Equity is not meaningful for Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome.
The higher the ratio, the more debt the company has in its capital structure.
Read More on HBR: Debt / Equity Ratio
The chart above depicts the distribution of debt / common equity for companies operating in the Financials sector in the Developed economic region. Over 2,830 companies were considered in this analysis, and 2,724 had meaningful values. The average debt / common equity of companies in the sector is 79.1% with a standard deviation of 144.8%.
Invesco Biotechnology & Genome ETF's Debt / Common Equity of - ranks in the - percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,838 |
| Included Constituents | 2,724 |
| Min | -88.1% |
| Max | 928.5% |
| Median | 20.0% |
| Mean | 79.1% |
| Standard Deviation | 144.8% |
You can find companies with similar debt / common equity using this stock screener.